Found 7 matching trials
Peanut Allergy Oral Immunotherapy Study of AR101 for Desensitization in Children and Adults (PALISADE)
PHASE3The purpose of this study is to demonstrate the efficacy and safety of AR10...
Location
Banner University of Arizona Medical Center
Peanut Oral Immunotherapy Study of Early Intervention for Desensitization
PHASE3The purpose of this study is to determine the efficacy and safety of AR101 ...
Location
Arkansas Children's Hospital
Oral Desensitization to Peanut in Peanut Allergic Children and Adults Using CPNA Peanut OIT Safety Follow-On Study
PHASE2This is a multi-center, open-label, follow-on study to gather additional in...
Location
Arkansas Children's Hospital
Study in Pediatric Subjects With Peanut Allergy to Evaluate Efficacy and Safety of Dupilumab as Adjunct to AR101 (Peanut Oral Immunotherapy)
PHASE2Primary objective is to assess whether dupilumab as adjunct to AR101 compar...
Location
Regeneron Investigational Site
ARTEMIS Peanut Allergy In Children
PHASE3The purpose of this study is to demonstrate the efficacy and safety of AR10...
Location
Unité de dermatologie Pédiatrique, Hôpital Pellegrin-Enfants, place Amélie Raba-Léon
Oral Desensitization to Peanut in Peanut-Allergic Children and Adults Using Characterized Peanut Allergen OIT
PHASE2This is a multi-center, randomized, double-blind placebo controlled study o...
Location
Arkansas Children's Hospital
Real-World AR101 Market-Supporting Experience Study in Peanut-Allergic Children (RAMSES)
PHASE3This is a multicenter, randomized, double-blind, placebo-controlled safety ...
Location
Clinical Research Center of Alabama